microdosing glp 1 athletes GLP-1 2026: 0.1mg Chart + Tolerance Schedule Guide GLP-1 Use in Athletes: Safety
Description
According to the Summary of Product Characteristics (SmPCs), headaches are classified as a 'common' side effect of GLP-1 medications used for weight management
Retatrutide is an investigational compound and is not FDA approved
Just feels really good overall, kinda surprised tbh
Clinical studies indicate decreases in inflammatory biomarkers, such as CRP (Verma et al
PlexusDx supports this informed decision-making through accessible genetic testing and evidence-based product options
Takes just a few minutes from your phone or computer
